At age eleven, Ryan Durant was diagnosed with Acute Lymphoblastic Leukemia. When Ryan's cancer proved to be resistant to standard chemotherapy treatments, his doctors recommend the CAR-T cell trial at Duke University. Ryan received his T-cells in January 2016 and has since remained cancer free!
At age seven, Emily Hunt was diagnosed with B-cell Acute Lymphoblastic Leukemia. When Emily's cancer returned following years of standard chemotherapy treatments, her parents sought out the CAR-T cell therapy clinical trial at Children's Hospital of Philadelphia. Emily received her T-cells in June 2014 and remains happy, healthy and 3 years cancer free.
At age five, Tori was diagnosed with Acute Lymphoblastic Leukemia. Following years of standard treatments, Tori became the 10th patient to receive her genetically engineered T-cells in the CAR T-cell trial at CHOP. Tori is now healthy and celebrating 4 years cancer free!
We celebrated an incredible milestone this month — on May 10, 2017 Emily reached five years cancer free! In acknowledgement, our co-founders discussed this milestone anniversary, the opportunities they have been blessed to experience, and the impact of the Emily Whitehead Foundation in an interview with The Philadelphia Inquirer.
At 3 years old, Austin was diagnosed with B-cell Acute Lymphoblastic Leukemia (ALL). When standard treatment options could no longer help, Austin was enrolled in the CAR T-cell trial at Children’s Hospital of Philadelphia. Now, Austin is a happy and healthy 8-year-old celebrating 3.5 years cancer free!